Affibody AB:企業のM&A・提携動向(医療分野)

【英語タイトル】Affibody AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(GDPH132814D)・商品コード:GDPH132814D
・発行会社(調査会社):GlobalData
・発行日:2017年1月25日
・ページ数:23
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥83,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Affibody AB (Affibody) is a biotechnology company that focuses on the development of next generation biopharmaceuticals based on its proprietary technology platforms, namely, Affibody molecules and Albumod, the half-life extension technology. The company’s Affibody molecules are a class of antibody mimetics, which surpass monoclonal antibodies and antibody fragments; and Albumod technology is designed to enhance the efficacy of biopharmaceuticals. Affibody’s pipeline projects include SOBI002 (C5), AFB-035 and IL-1 biology, for inflammation and autoimmune disorders; HER2 radiotherapy, for cancer; ABY-025/GE226 and ABY-026, for cancer diagnostics; and others. Some of the company’s major partners include Amylin, Daiichi Sankyo, Daewoong, Swedish Orphan Biovitrum, GE Healthcare and others. Affibody is headquartered in Solna, Sweden.

Affibody AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Affibody AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Affibody AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Affibody AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Affibody AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Affibody AB, Medical Devices Deals, 2011 to YTD 2017 9
Affibody AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Affibody AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Nordic Nanovector Enters into Co-Development Agreement with Affibody 11
Swedish Orphan Biovitrum Enters Into Research Agreement With Affibody 11
Affibody Enters Into Co-Development Agreement With Creative Antibiotics 12
Affibody Enters Into Co-Development Agreement With Nuclisome 13
Licensing Agreements 14
Swedish Orphan Biovitrum Exercises Option for Licensing Agreement with Affibody for IL-1 14
Affibody Enters into Licensing Agreement with Biotest 15
Affibody Enters Into Licensing Agreement With Daiichi Sankyo For Albumod 16
AbClon Enters into Licensing Agreement with Affibody 16
Affibody Enters into Licensing Agreement with Daewoong Pharma for Albumod 17
Algeta Enters Into Licensing Agreement With Affibody 18
Affibody AB – Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Affibody AB, Pharmaceuticals & Healthcare, Key Facts 1
Affibody AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Affibody AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Affibody AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Affibody AB, Deals By Therapy Area, 2011 to YTD 2017 8
Affibody AB, Medical Devices Deals, 2011 to YTD 2017 9
Affibody AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nordic Nanovector Enters into Co-Development Agreement with Affibody 11
Swedish Orphan Biovitrum Enters Into Research Agreement With Affibody 11
Affibody Enters Into Co-Development Agreement With Creative Antibiotics 12
Affibody Enters Into Co-Development Agreement With Nuclisome 13
Swedish Orphan Biovitrum Exercises Option for Licensing Agreement with Affibody for IL-1 14
Affibody Enters into Licensing Agreement with Biotest 15
Affibody Enters Into Licensing Agreement With Daiichi Sankyo For Albumod 16
AbClon Enters into Licensing Agreement with Affibody 16
Affibody Enters into Licensing Agreement with Daewoong Pharma for Albumod 17
Algeta Enters Into Licensing Agreement With Affibody 18
Affibody AB, Key Competitors 20
Affibody AB, Key Employees 21

List of Figures
Affibody AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Affibody AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Affibody AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Affibody AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Affibody AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Affibody AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Affibody AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Affibody AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Affibody AB, Medical Devices Deals, 2011 to YTD 2017 9

★調査レポート[Affibody AB:企業のM&A・提携動向(医療分野)] (コード:GDPH132814D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Affibody AB:企業のM&A・提携動向(医療分野)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆